Biogen | 8-K: Current report
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Singhal Priya
Biogen | 144: Notice of proposed sale of securities pursuant to Rule 144
Biogen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Biogen Inc.(1.6%),Biogen MA Inc.(1.6%)
Biogen | 8-K: Current report
Biogen | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.1%)
Biogen | 10-Q: Q2 2024 Earnings Report
Biogen | 8-K: Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28
Biogen | 4: Statement of changes in beneficial ownership of securities-Director SHERWIN STEPHEN A
Biogen | 4: Statement of changes in beneficial ownership of securities-Director Rowinsky Eric K
Biogen | 4: Statement of changes in beneficial ownership of securities-Director Mantas Jesus B
Biogen | 4: Statement of changes in beneficial ownership of securities-Director LANGER SUSAN
Biogen | 4: Statement of changes in beneficial ownership of securities-Director Patolawala Monish D
Biogen | 4: Statement of changes in beneficial ownership of securities-Director Freire Maria C
Biogen | 4: Statement of changes in beneficial ownership of securities-Director HAWKINS WILLIAM A
Biogen | 4: Statement of changes in beneficial ownership of securities-Director DORSA CAROLINE
Biogen | 8-K: Current report
Biogen | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biogen | 4: Statement of changes in beneficial ownership of securities-Officer Keeney Adam
Biogen | ARS: Annual Report to Security Holders
No Data
No Data